This week’s signals tell a different kind of story: the capital stack for women’s health is quietly evolving through asset deals, institutional alliances, and science-driven care platforms.
From biotech acquisitions in ovarian aging to the institutional signaling power of the Milken Institute, this isn’t hype. It’s architecture. The scaffolding is going …